Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer

NCT01787006 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Cetuximab
DRUG: Cisplatin, 5-FU
RADIATION: Radiotherapy

Sponsor

University Hospital Schleswig-Holstein